Clinical Trial Update: Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males. [Phase 1]

View source ↗

Summary

Phase 1 bioavailability study of two combination products containing dutasteride 0.5 mg and tamsulosin 0.2 mg, evaluated in Asian male participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• DUTASTERIDE (Dutasteride)
• Tamsulosin (tamsulosin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Prostatic Hyperplasia | Phase 1 | Status: COMPLETED